Trulieve Cannabis Corp. (OTC: TCNNF) Stock Transaction and Q1 2026 Performance Amidst Rescheduling

• A significant insider stock transaction for Trulieve Cannabis Corp. (OTC: TCNNF) was reported on May 6, 2026.
• The cannabis multi-state operator (MSO) demonstrated robust Q1 2026 financial performance with $287 million in revenue and $100 million in Adjusted EBITDA.
• The U.S. government's rescheduling of medical marijuana is poised to deliver substantial tax savings and new growth avenues for Trulieve.

On May 6, 2026, a notable cannabis stock transaction involved Trulieve Cannabis Corp. (OTC: TCNNF), with a sale executed by Greg Stanton's spouse. Trulieve Cannabis Corp. is a leading multi-state operator (MSO) that grows, processes, and sells cannabis products. Its primary competitors include other large MSOs like Curaleaf Holdings and Green Thumb Industries.

The sale was valued between $15,001.00 and $50,000.00. This transaction occurred as Trulieve Cannabis Corp. navigates a changing cannabis industry landscape. Trulieve Cannabis Corp. currently operates 206 dispensaries and has over 3.5 million square feet of production capacity, positioning it as a major player in the U.S. cannabis market.

This event coincides with Trulieve Cannabis Corp. reporting strong first-quarter 2026 results. The company generated revenue of $287 million with a 59% gross margin. It also achieved a positive net income of $2 million and an Adjusted EBITDA of $100 million, showing solid profitability and cash flow.

A key cannabis industry development is the U.S. government's rescheduling of medical marijuana to a Schedule III substance. As highlighted by The Motley Fool, this cannabis reform is a huge milestone. It allows companies like Trulieve Cannabis Corp. to claim more business expenses, which is expected to result in significant tax savings.

Following this change, Trulieve Cannabis Corp. is applying for DEA registration to explore new investment opportunities. The company's stock is currently trading at $9.35, giving it a market capitalization of about $1.8 billion. Over the past year, the stock has traded between a low of $3.25 and a high of $11.83.